US00847J1051 - Common Stock - After market: 82.99 0 (0%)
On Tuesday, National Instruments stock reached a key technical milestone, seeing its Relative Strength Rating jump to 91.
These stocks to sell seem overvalued, as their business models have failed to gain the significant traction they need.
GH dropped on clinical data; COF extended recent losses to hit a new 52-week low. MAXR more than doubled on news of a takeover deal. AGYS set a fresh 52-week high.